<table border="0" cellpadding="0" cellspacing="0" width="border-collapse: collapse" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Antacids and Sucralfate </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant administration of some antacids (magnesium oxide or aluminum hydroxide) and sucralfate can delay the absorption of naproxen. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant administration of antacids such as magnesium oxide or aluminum hydroxide, and sucralfate with naproxen is not recommended. Due to the gastric pH elevating effects of H2-blockers, sucralfate and intensive antacid therapy, concomitant administration of naproxen is not recommended. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Cholestyramine </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant administration of cholestyramine can delay the absorption of naproxen. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant administration of cholestyramine with naproxenis not recommended. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Probenecid </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Probenecid given concurrently increases naproxen anion plasma levels and extends its plasma half-life significantly. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Patients simultaneously receiving naproxen and probenecid should be observed for adjustment of dose if required. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Other albumin-bound drugs </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Naproxen is highly bound to plasma albumin; it thus has a theoretical potential for interaction with other albumin-bound drugs such as coumarin-type anticoagulants, sulphonylureas, hydantoins, other NSAIDs, and aspirin<content stylecode="italics">. </content>
<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention: </content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Patients simultaneously receiving naproxen and a hydantoin, sulphonamide or sulphonylurea should be observed for adjustment of dose if required. <br/>
</td>
</tr>
</tbody>
</table>